Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia

J. Khalife, H. S. Radomska, R. Santhanam, X. Huang, P. Neviani, J. Saultz, H. Wang, Y. Z. Wu, H. Alachkar, M. Anghelina, A. Dorrance, J. Curfman, C. D. Bloomfield, B. C. Medeiros, D. Perrotti, L. J. Lee, R. J. Lee, M. A. Caligiuri, F. Pichiorri, C. M. CroceR. Garzon, M. L. Guzman, J. H. Mendler, G. Marcucci

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint Dive into the research topics of 'Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences